1. Home
  2. FRA vs NAUT Comparison

FRA vs NAUT Comparison

Compare FRA & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock Floating Rate Income Strategies Fund Inc

FRA

Blackrock Floating Rate Income Strategies Fund Inc

SELL

Current Price

$9.92

Market Cap

395.1M

Sector

Finance

ML Signal

SELL

Logo Nautilus Biotechnolgy Inc.

NAUT

Nautilus Biotechnolgy Inc.

HOLD

Current Price

$3.13

Market Cap

330.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRA
NAUT
Founded
2003
2016
Country
United States
United States
Employees
N/A
130
Industry
Investment Bankers/Brokers/Service
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
395.1M
330.9M
IPO Year
2003
2020

Fundamental Metrics

Financial Performance
Metric
FRA
NAUT
Price
$9.92
$3.13
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $3.83
AVG Volume (30 Days)
177.5K
★ 8.6M
Earning Date
01-01-0001
10-27-2026
Dividend Yield
★ 11.06%
N/A
EPS Growth
N/A
★ 16.07
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$862.33
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.98
$0.84
52 Week High
$12.71
$4.31

Technical Indicators

Market Signals
Indicator
FRA
NAUT
Relative Strength Index (RSI) 23.57 79.20
Support Level N/A $2.28
Resistance Level $11.18 $4.31
Average True Range (ATR) 0.12 0.41
MACD -0.02 0.09
Stochastic Oscillator 34.67 93.29

Price Performance

Historical Comparison
FRA
NAUT

About FRA Blackrock Floating Rate Income Strategies Fund Inc

Blackrock Floating Rate Inc Stra Fd Inc is a closed-end management investment company. Its investment objective is to provide shareholders with high current income and such preservation of capital as is consistent with investment in a diversified, leveraged portfolio consisting of floating rate debt securities and instruments. The Fund seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its managed assets in floating rate debt securities, including floating or variable rate debt securities that pay interest at rates that adjust whenever a specified interest rate changes and/or which reset on predetermined dates (such as the last day of a month or calendar quarter).

About NAUT Nautilus Biotechnolgy Inc.

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.

Share on Social Networks: